News & Updates

Show Multimedia Only
GLP-1 RAs vs SGLT2 inhibitors: What are the comparative risks of ischaemic stroke and incident AF?

GLP-1 RAs vs SGLT2 inhibitors: What are the comparative risks of ischaemic stroke and incident AF?

08 Mar 2023 byNatalia Reoutova

A population-based retrospective study of Hong Kong patients with type 2 diabetes (T2D) finds that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a lower risk of ischaemic stroke, while use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a lower risk of atrial fibrillation (AF).

08 Mar 2023
HPV infection ups CVD risk, but not in vaccinated women

HPV infection ups CVD risk, but not in vaccinated women

02 Mar 2023

Human papillomavirus (HPV) infection appears to be a risk factor for cardiovascular diseases (CVDs), suggests a recent study. However, women vaccinated against HPV are protected against such risk.

02 Mar 2023
Which factors shape decisions to withdraw life support in stroke patients?

Which factors shape decisions to withdraw life support in stroke patients?

02 Mar 2023 byStephen Padilla

The decision to withdraw life-sustaining therapy (WLST) among acute hospitalized stroke patients is determined by several factors, including age, race, level of consciousness, state region, insurance status, ambulation status at baseline, and stroke centre type, suggests a study presented at ISC 2023.

02 Mar 2023
Statin therapy reduces major vascular events after stroke

Statin therapy reduces major vascular events after stroke

01 Mar 2023 byStephen Padilla

Treatment with statin results in a decrease in major vascular events following acute ischaemic stroke, even in patients with low or well-controlled low-density lipoprotein cholesterol (LDL-C), as shown in a study presented at ISC 2023.

01 Mar 2023